Literature DB >> 17487136

Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis.

Suchittra Samuhasaneeto1, Duangporn Thong-Ngam, Onanong Kulaputana, Suthiluk Patumraj, Naruemon Klaikeaw.   

Abstract

OBJECTIVE: Prove the attenuated effects of N-acetylcysteine (NAC) on oxidative stress in rats with nonalcoholic steatohepatitis (NASH). MATERIAL AND
METHOD: Male Sprague-Dawley rats were randomly divided into five groups. Group I (normal control) was fed regular dry rat chow (RC) for 6 weeks. Group 2 (NASH) was fed 100% fat diet for 6 weeks. Group 3-5 were fed 100% fat diet for 6 weeks, and then switched to RC alone (NASH + diet ; group 3), to RC + 20 mg/kg/day of NAC orally (NASH + diet + NAC20; group 4) or to RC + 500 mg/kg/day of NAC orally (NASH + diet + NAC500; group 5) for 4 weeks, respectively. They were sacrificed to collect blood and liver samples at the end of the present study.
RESULTS: Levels of total glutathione (GSH), serum cholesterol, and hepatic malondialdehyde (MDA) were increased significantly in the NASH group compared with normal control. Liver histopathology from group 2 showed moderate to severe macrovesicular steatosis, hepatocyte ballooning, and necroinflammation. Treatment with diet or diet plus NAC reduced the levels of GSH, cholesterol, and hepatic MDA back to normal. Liver sections from group 3-5 showed a decrease in fat deposition and necroinflammation in hepatocytes. However, no differences on all variables existed between diet alone and diet plus NAC groups.
CONCLUSION: Our data indicate that diet or diet plus NAC treatment could attenuate oxidative stress and improve liver histopathology of NASH. However the addition of NAC is not better than diet treatment alone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487136

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  13 in total

1.  Limited therapeutic effect of N-acetylcysteine on hepatic insulin resistance in an experimental model of alcohol-induced steatohepatitis.

Authors:  Mashiko Setshedi; Lisa Longato; Dennis R Petersen; Martin Ronis; William C Chen; Jack R Wands; Suzanne M de la Monte
Journal:  Alcohol Clin Exp Res       Date:  2011-07-25       Impact factor: 3.455

Review 2.  Antioxidants as therapeutic agents for liver disease.

Authors:  Ashwani K Singal; Sarat C Jampana; Steven A Weinman
Journal:  Liver Int       Date:  2011-07-29       Impact factor: 5.828

3.  N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis.

Authors:  Duangporn Thong-Ngam; Suchittra Samuhasaneeto; Onanong Kulaputana; Naruemon Klaikeaw
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

4.  The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats.

Authors:  Madiha Dhibi; Faten Brahmi; Amira Mnari; Zohra Houas; Issam Chargui; Linda Bchir; Noureddine Gazzah; Mohammed A Alsaif; Mohamed Hammami
Journal:  Nutr Metab (Lond)       Date:  2011-09-23       Impact factor: 4.169

5.  N-acetylcysteine improves liver function in patients with non-alcoholic Fatty liver disease.

Authors:  Manouchehr Khoshbaten; Akbar Aliasgarzadeh; Koorosh Masnadi; Mohammad K Tarzamani; Sara Farhang; Hosain Babaei; Javad Kiani; Maryam Zaare; Farzad Najafipoor
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660

Review 6.  Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies.

Authors:  Yue Ye Huang; Aaron M Gusdon; Shen Qu
Journal:  Lipids Health Dis       Date:  2013-11-09       Impact factor: 3.876

7.  Reduced oxidative stress contributes to the lipid lowering effects of isoquercitrin in free fatty acids induced hepatocytes.

Authors:  Waseem Hassan; Gao Rongyin; Abdelkader Daoud; Lin Ding; Lulu Wang; Jun Liu; Jing Shang
Journal:  Oxid Med Cell Longev       Date:  2014-10-22       Impact factor: 6.543

Review 8.  Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine.

Authors:  Kívia Queiroz de Andrade; Fabiana Andréa Moura; John Marques dos Santos; Orlando Roberto Pimentel de Araújo; Juliana Célia de Farias Santos; Marília Oliveira Fonseca Goulart
Journal:  Int J Mol Sci       Date:  2015-12-18       Impact factor: 5.923

9.  Is N-acetylcysteine infusion an effective treatment option in L-asparaginase associated hepatotoxicity?

Authors:  Zeynep Canan Özdemir; Ayşe Bozkurt Turhan; Makbule Eren; Özcan Bor
Journal:  Blood Res       Date:  2017-03-27

10.  Antidiabetic activity of the ethyl acetate fraction of Ficus lutea (Moraceae) leaf extract: comparison of an in vitro assay with an in vivo obese mouse model.

Authors:  Oyinlola O Olaokun; Lyndy J McGaw; Ilse Janse van Rensburg; Jacobus N Eloff; Vinny Naidoo
Journal:  BMC Complement Altern Med       Date:  2016-03-31       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.